Cargando…
Correspondence: Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803208/ https://www.ncbi.nlm.nih.gov/pubmed/29416027 http://dx.doi.org/10.1038/s41467-017-02654-2 |
| _version_ | 1783298641669128192 |
|---|---|
| author | Cilibrizzi, Agostino |
| author_facet | Cilibrizzi, Agostino |
| author_sort | Cilibrizzi, Agostino |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5803208 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-58032082018-02-09 Correspondence: Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury Cilibrizzi, Agostino Nat Commun Correspondence Nature Publishing Group UK 2018-02-07 /pmc/articles/PMC5803208/ /pubmed/29416027 http://dx.doi.org/10.1038/s41467-017-02654-2 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Cilibrizzi, Agostino Correspondence: Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury |
| title | Correspondence: Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury |
| title_full | Correspondence: Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury |
| title_fullStr | Correspondence: Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury |
| title_full_unstemmed | Correspondence: Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury |
| title_short | Correspondence: Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury |
| title_sort | correspondence: compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803208/ https://www.ncbi.nlm.nih.gov/pubmed/29416027 http://dx.doi.org/10.1038/s41467-017-02654-2 |
| work_keys_str_mv | AT cilibrizziagostino correspondencecompound17bandformylpeptidereceptorbiasedagonisminrelationtocardioprotectiveeffectsinischaemiareperfusioninjury |